Literature DB >> 20890879

Time-dependent effects of rifampicin on staphylococcal biofilms.

Klaus-Bernhard Gattringer1, Miranda Suchomel, Michaela Eder, Andrea M Lassnigg, Wolfgang Graninger, Elisabeth Presterl.   

Abstract

OBJECTIVE: To test the time-dependent effects of rifampicin on established biofilms of Staphylococcus epidermidis isolated from patients with cardiac implant infections and catheter-related bacteremia.
METHODS: Biofilms were grown in microtiter plates for 24 hours, dyed and stained with crystal violet. The mean optical density (OD) was used for quantification. The OD ratio (ODr = OD of the treated biofilm/OD of the untreated biofilm) was used to measure changes in the thickness of the biofilms over the time. Biofilms were incubated with rifampicin (0.6 mg/mL) for 1, 5, 15, 30 and 60 minutes. Unstained biofilms were sonicated and plated on Columbia agar for time-kill curves.
RESULTS: The incubation of the biofilms with rifampicin led to a significant reduction of the OD of the biofilms within 1 minute (ODr baseline: 1; ODr 1 min: 0.333 ± 0.131) (p<0.001). With regard to bacterial killing, rifampicin reduced the mean log count, but viable bacteria were still grown from biofilms in 13 out of 28 isolates despite MIC values < 0.01 mg/L.
CONCLUSIONS: In conclusion, our results confirm that rifampicin at a concentration of 1.2 mg/mL immediately reduces established biofilms formed by S. epidermidis although it is not bactericidal despite very low MICs at planktonic conditions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20890879     DOI: 10.1177/039139881003300907

Source DB:  PubMed          Journal:  Int J Artif Organs        ISSN: 0391-3988            Impact factor:   1.595


  4 in total

1.  Does Extracellular DNA Production Vary in Staphylococcal Biofilms Isolated From Infected Implants versus Controls?

Authors:  Beata Zatorska; Marion Groger; Doris Moser; Magda Diab-Elschahawi; Luigi Segagni Lusignani; Elisabeth Presterl
Journal:  Clin Orthop Relat Res       Date:  2017-02-13       Impact factor: 4.176

2.  Proteomics-based screening and antibiotic resistance assessment of clinical and sub-clinical Brucella species: An evolution of brucellosis infection control.

Authors:  Ayman Elbehiry; Musaad Aldubaib; Osamah Al Rugaie; Eman Marzouk; Marwan Abaalkhail; Ihab Moussa; Mohamed H El-Husseiny; Adil Abalkhail; Mohammed Rawway
Journal:  PLoS One       Date:  2022-01-13       Impact factor: 3.240

3.  In vitro antimicrobial susceptibility testing of human Brucella melitensis isolates from Ulanqab of Inner Mongolia, China.

Authors:  Zhi-Guo Liu; Dong-Dong Di; Miao Wang; Ri-Hong Liu; Hong-Yan Zhao; Dong-Ri Piao; Zhong-Zhi Zhao; Yong-Qing Hao; Ya-Nan Du; Hai Jiang; Bu-Yun Cui; Xian-Zhu Xia
Journal:  BMC Infect Dis       Date:  2018-01-16       Impact factor: 3.090

4.  Antimicrobial susceptibility of Brucella spp. isolated from Iranian patients during 2016 to 2018.

Authors:  Saeed Alamian; Maryam Dadar; Afshar Etemadi; Davoud Afshar; Mohammad Mehdi Alamian
Journal:  Iran J Microbiol       Date:  2019-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.